JoinClinicalTrials.com

• Study of Changes in Retrofoveolar Choroidal Thickness During Aerobic Exercise

  NCT03532867

  Conditions:   Choroid Disease;   Hypertension Ocular
  Interventions:   Other: Examination of pressures before stopping the exercise;   Other: Examination of pressure during the exercise;   Other: Examination of pressures after stopping the exercise
  Sponsor:   University Hospital, Toulouse
  Not yet recruiting
• Advanced OCT and Adaptive Optics Imaging in Retinal Disease (The ACAD Study)

  NCT02828215

  Conditions:   Vitreous Diseases;   Retinal Diseases;   Choroidal Diseases
  Intervention:   Device: Swept-source optical coherence tomography (SS-OCT)
  Sponsor:   Moorfields Eye Hospital NHS Foundation Trust
  Recruiting
• OCT in Rare Chorioretinal Diseases

  NCT02141308

  Conditions:   Retinal Artery Occlusions;   Polypoidal Choroidal Vasculopathy;   Retinal Arterial Macroaneurysm;   Juxtafoveal Telangiecasia;   Central Serous Chorioretinopathy
  Intervention:  
  Sponsor:   Oregon Health and Science University
  Recruiting
• Efficacy and Safety of H.P. Acthar® Gel in Subjects With Severe Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis NIPPU

  NCT03656692

  Conditions:   Uveitis, Posterior;   Uveitis, Intermediate;   Panuveitis
  Intervention:   Drug: Acthar
  Sponsor:   Mallinckrodt
  Recruiting
• Intravitreal Sirolimus as Therapeutic Approach to Uveitis

  NCT01280669

  Conditions:   Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis
  Interventions:   Drug: Intravitreal injection 440mcg;   Drug: Intravitreal injection of sirolimus 880mcg
  Sponsors:   Stanford University;   Santen Inc.
  Recruiting
• OCT and Microperimetry in Patients With Active Neovascular ARMD (CORFI)

  NCT03435926

  Condition:   Choroidal Neovascularization, Visual Field, Visual Acuity
  Intervention:  
  Sponsor:   University Hospital, Limoges
  Recruiting
• Intravitreal Conbercept Injection in Patients With Myopic Choroidal Neovascularization

  NCT03971162

  Condition:   Myopic Choroidal Neovascularisation
  Interventions:   Drug: 3+PRN;   Drug: 6+PRN
  Sponsor:   Zhongshan Ophthalmic Center, Sun Yat-sen University
  Recruiting
• Real Life Study in Myopic Neovascularization

  NCT03797547

  Condition:   Myopic Choroidal Neovascularisation
  Intervention:   Other: AFLIBERCEPT
  Sponsor:   Poitiers University Hospital
  Recruiting
• A Safety Study of Retinal Gene Therapy for Choroideremia

  NCT03507686

  Condition:   Choroideremia
  Intervention:   Drug: AAV2-REP1
  Sponsor:   NightstaRx Ltd
  Recruiting
• Efficacy and Safety of AAV2-REP1 for the Treatment of Choroideremia

  NCT03496012

  Condition:   Choroideremia
  Intervention:   Genetic: AAV2-REP1
  Sponsor:   NightstaRx Ltd
  Recruiting
• Natural History of the Progression of Choroideremia Study

  NCT03359551

  Condition:   Choroideremia
  Intervention:  
  Sponsor:   NightstaRx Ltd
  Recruiting
• Shanghai Beixinjing Diabetic Eyes Study

  NCT03571217

  Conditions:   Diabetic Retinopathy;   Visual Impairment;   Diabetic Maculopathy
  Intervention:  
  Sponsor:   Shanghai Eye Disease Prevention and Treatment Center
  Recruiting
• Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia

  NCT03963596

  Condition:   Pathologic Myopia
  Intervention:   Procedure: Intravitreal injection
  Sponsors:   The Filatov Institute of Eye Diseases and Tissue Therapy;   Odessa National Medical University;   Mykolaiv Region Ophthalmogical Hospital
  Recruiting
• A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

  NCT03844074

  Conditions:   Age-related Macular Degeneration;   Neovascular Age-related Macular Degeneration;   Wet Macular Degeneration
  Interventions:   Biological: bevacizumab;   Biological: ranibizumab
  Sponsor:   Outlook Therapeutics, Inc.
  Recruiting
• A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

  NCT03834753

  Conditions:   Age-related Macular Degeneration;   Neovascular Age-related Macular Degeneration;   Wet Macular Degeneration
  Interventions:   Biological: bevacizumab;   Biological: ranibizumab
  Sponsor:   Outlook Therapeutics, Inc.
  Recruiting
• Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection

  NCT02486484

  Conditions:   Neovascularization;   Macular Degeneration;   Diabetic Retinopathy;   Retinal Vein Occlusion;   Choroidal Neovascularization;   Retinal Neovascularization;   Recurrent Pterygium;   Cystoid Macular Edema
  Intervention:   Drug: ziv-aflibercept
  Sponsor:   Rafic Hariri University Hospital
  Recruiting
• Inherited Retinal Degenerative Disease Registry

  NCT02435940

  Conditions:   Eye Diseases Hereditary;   Retinal Disease;   Achromatopsia;   Bardet-Biedl Syndrome;   Bassen-Kornzweig Syndrome;   Batten Disease;   Best Disease;   Choroidal Dystrophy;   Choroideremia;   Cone Dystrophy;   Cone-Rod Dystrophy;   Congenital Stationary Night Blindness;   Enhanced S-Cone Syndrome;   Fundus Albipunctatus;   Goldmann-Favre Syndrome;   Gyrate Atrophy;   Juvenile Macular Degeneration;   Kearns-Sayre Syndrome;   Leber Congenital Amaurosis;   Refsum Syndrome;   Retinitis Pigmentosa;   Retinitis Punctata Albescens;   Retinoschisis;   Rod-Cone Dystrophy;   Rod Dystrophy;   Rod Monochromacy;   Stargardt Disease;   Usher Syndrome
  Intervention:  
  Sponsor:   Foundation Fighting Blindness
  Recruiting
• Imaging of the Angiofibrotic Switch in Neovascular AMD

  NCT03838679

  Conditions:   Age-related Macular Degeneration;   Choroidal Neovascularization
  Interventions:   Diagnostic Test: Best-corrected Visual acuity testing (BCVA);   Diagnostic Test: Optical coherence tomography (OCT);   Diagnostic Test: Color fundus photography (CFP);   Diagnostic Test: Optical coherence tomography angiography (OCTA);   Diagnostic Test: Polarization-sensitive optical coherence tomography (PS-OCT);   Diagnostic Test: Microperimetry (MP);   Diagnostic Test: Adaptive-optics optical coherence tomography (AO-OCT);   Diagnostic Test: Fluorescein angiography (FA)
  Sponsor:   Medical University of Vienna
  Recruiting
• Episcleral Brachytherapy for the Treatment of Wet AMD

  NCT02988895

  Condition:   Macular Degeneration, Choroidal Neovascularization
  Intervention:   Radiation: episcleral brachytherapy
  Sponsor:   Salutaris Medical Devices, Inc.
  Recruiting
• High Resolution Retinal Imaging

  NCT01866371

  Conditions:   Stargardts;   Retinitis Pigmentosa;   Age-related Macular Degeneration;   Choroideremia;   Geographic Atrophy
  Intervention:   Procedure: Retinal imaging
  Sponsors:   University of Pennsylvania;   National Eye Institute (NEI)
  Recruiting